APLIF: DSMB Recommends for PRESECO Trial to Complete; Data Expected in 3Q21… msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has undergone a transformation over the past year as it has built up a robust pipeline of clinical stage assets focused on the treatment of central nervous system (CNS) and immunological diseases. In addition, the company’s balance sheet has never been stronger. As of March 31, 2021, Tonix had approximately $164.2.
Company Connecting the Dots for Final FDA Approval
New York, New York (Newsfile Corp. - June 3, 2021) - PCG Digital When Soligenix (NASDAQ: SNGX) updated its NDA rollout plan, the market quickly reacted.